1、 RUAN P,WANG S,YANG C,et al.m6A mRNA methylation regulates the ERK/NF-κB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer[J].Cell Biol Toxicol,2023,39(4):1611-1626. RUAN P,WANG S,YANG C,et al.m6A mRNA methylation regulates the ERK/NF-κB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer[J].Cell Biol Toxicol,2023,39(4):1611-1626.
2、 DIéGUEZ-MARTíNEZ N,ESPINOSA-GIL S,YOLDI G,et al.The ERK5/NF-kB signaling pathway targets endometrial cancer proliferation and survival[J].Cell Mol Life Sci,2022,79(10):524. DIéGUEZ-MARTíNEZ N,ESPINOSA-GIL S,YOLDI G,et al.The ERK5/NF-kB signaling pathway targets endometrial cancer proliferation and survival[J].Cell Mol Life Sci,2022,79(10):524.
3、 ZHAO H,YIN X,WANG L,et al.Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer[J].Sci Data,2023,10(1):119. ZHAO H,YIN X,WANG L,et al.Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer[J].Sci Data,2023,10(1):119.
4、 LIU Y,CAI X,CAI Y,et al.IncRNA OIP5-AS1 suppresses cell proliferation and invasion of endometrial cancer by regulating PTEN/AKT via sponging miR-200c-3p[J].J Immunol Res,2021(2021):4861749. LIU Y,CAI X,CAI Y,et al.IncRNA OIP5-AS1 suppresses cell proliferation and invasion of endometrial cancer by regulating PTEN/AKT via sponging miR-200c-3p[J].J Immunol Res,2021(2021):4861749.
5、 DONG P,XIONG Y,KONNO Y,et al.Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway[J].J Exp Clin Cancer Res,2021,40(1):216. DONG P,XIONG Y,KONNO Y,et al.Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway[J].J Exp Clin Cancer Res,2021,40(1):216.
6、 TAN Y T,LIN J F,LI T,et al.LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer[J].Cancer Commun(Lond),2021,41(2):109-120. TAN Y T,LIN J F,LI T,et al.LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer[J].Cancer Commun(Lond),2021,41(2):109-120.
7、 CHEN L L.Linking long noncoding RNA localization and function[J].Trends Biochem Sci,2016,41(9):761-772. CHEN L L.Linking long noncoding RNA localization and function[J].Trends Biochem Sci,2016,41(9):761-772.
8、 YAO Z T,YANG Y M,SUN M M,et al.New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer[J].Cancer Commun(Lond),2022,42(2):117-140. YAO Z T,YANG Y M,SUN M M,et al.New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer[J].Cancer Commun(Lond),2022,42(2):117-140.
9、 BROOKS R A,FLEMING G F,LASTRA R R,et al.Current recommendations and recent progress in endometrial cancer[J].CA Cancer J Clin,2019,69(4):258-279. BROOKS R A,FLEMING G F,LASTRA R R,et al.Current recommendations and recent progress in endometrial cancer[J].CA Cancer J Clin,2019,69(4):258-279.
10、 CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
11、 MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021,7(1):88. MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021,7(1):88.
12、 LIU W,ZHANG Z,LUO X,et al.m6A-mediated LINC02038 inhibits colorectal cancer progression via regulation of the FAM172A/PI3K/AKT pathway via competitive binding with miR-552-5p[J].Int J Oncol,2023,63(1):81. LIU W,ZHANG Z,LUO X,et al.m6A-mediated LINC02038 inhibits colorectal cancer progression via regulation of the FAM172A/PI3K/AKT pathway via competitive binding with miR-552-5p[J].Int J Oncol,2023,63(1):81.
13、 FANG Y,FULLWOOD M J.Roles,functions,and mechanisms of long non-coding RNAs in cancer[J].Genomics Proteomics Bioinformatics,2016,14(1):42-54. FANG Y,FULLWOOD M J.Roles,functions,and mechanisms of long non-coding RNAs in cancer[J].Genomics Proteomics Bioinformatics,2016,14(1):42-54.
14、 BHAN A,SOLEIMANI M,MANDAL S S.Long noncoding RNA and cancer:A new paradigm[J].Cancer Res,2017,77(15):3965-3981. BHAN A,SOLEIMANI M,MANDAL S S.Long noncoding RNA and cancer:A new paradigm[J].Cancer Res,2017,77(15):3965-3981.
15、 BATISTA P J,CHANG H Y.Long noncoding RNAs:Cellular address codes in development and disease[J].Cell,2013,152(6):1298-1307. BATISTA P J,CHANG H Y.Long noncoding RNAs:Cellular address codes in development and disease[J].Cell,2013,152(6):1298-1307.
16、 ADNANE S,MARINO A,LEUCCI E.LncRNAs in human cancers:Signal from noise[J].Trends Cell Biol,2022,32(7):565-573. ADNANE S,MARINO A,LEUCCI E.LncRNAs in human cancers:Signal from noise[J].Trends Cell Biol,2022,32(7):565-573.
17、 KOPP F,MENDELL J T.Functional classification and experimental dissection of long noncoding RNAs[J].Cell,2018,172(3):393-407. KOPP F,MENDELL J T.Functional classification and experimental dissection of long noncoding RNAs[J].Cell,2018,172(3):393-407.
18、 RINN J L,CHANG H Y.Long noncoding RNAs:Molecular modalities to organismal functions[J].Annu Rev Biochem,2020(89):283-308. RINN J L,CHANG H Y.Long noncoding RNAs:Molecular modalities to organismal functions[J].Annu Rev Biochem,2020(89):283-308.
19、 HERMAN A B,TSITSIPATIS D,GOROSPE M.Integrated lncRNA function upon genomic and epigenomic regulation[J].Mol Cell,2022,82(12):2252-2266. HERMAN A B,TSITSIPATIS D,GOROSPE M.Integrated lncRNA function upon genomic and epigenomic regulation[J].Mol Cell,2022,82(12):2252-2266.
20、 SOSLOW R A,TORNOS C,PARK K J,et al.Endometrial carcinoma diagnosis:Use of FIGO grading and genomic subcategories in clinical practice:Recommendations of the international society of gynecological pathologists[J].Int J Gynecol Pathol,2019,38 Suppl 1(Iss 1 Suppl 1):S64-S74. SOSLOW R A,TORNOS C,PARK K J,et al.Endometrial carcinoma diagnosis:Use of FIGO grading and genomic subcategories in clinical practice:Recommendations of the international society of gynecological pathologists[J].Int J Gynecol Pathol,2019,38 Suppl 1(Iss 1 Suppl 1):S64-S74.
21、 HUVILA J,PORS J,THOMPSON E F,et al.Endometrial carcinoma:Molecular subtypes,precursors and the role of pathology in early diagnosis[J].J Pathol,2021,253(4):355-365. HUVILA J,PORS J,THOMPSON E F,et al.Endometrial carcinoma:Molecular subtypes,precursors and the role of pathology in early diagnosis[J].J Pathol,2021,253(4):355-365.
22、 CAO W,CHEN H D,YU Y W,et al.Changing profiles of cancer burden worldwide and in China:A secondary analysis of the global cancer statistics 2020[J].Chin Med J(Engl),2021,134(7):783-791. CAO W,CHEN H D,YU Y W,et al.Changing profiles of cancer burden worldwide and in China:A secondary analysis of the global cancer statistics 2020[J].Chin Med J(Engl),2021,134(7):783-791.
23、 SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
